. . . . "Fomepizole"@en . . . . . "Headache, nausea, dizziness"@en . "7554-65-6"@en . "Fomepizole"@en . . . . . . . . . . "Fomepizole is used as an antidote in confirmed or suspected methanol or ethylene glycol poisoning. Fomepizole is a competitive inhibitor of alcohol dehydrogenase, the enzyme that catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites."@en . . . . . "Antizol (fomepizole) is a competitive inhibitor of alcohol dehydrogenase. Alcohol dehydrogenase catalyzes the oxidation of ethanol to acetaldehyde. Alcohol dehydrogenase also catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites."@en . . "4-Methylpyrazol"@en . . . . "The plasma half-life of Antizol varies with dose, even in patients with normal renal function, and has not been calculated."@en . . . "Fomepizol"@en . "Antizol is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis"@en . "approved"@en . " "@en . "* 0.6 to 1.02 L/kg"@en . . . . . . "Antizol"@en . . . . . . . . . . . . . . . . . . . . "Rapid and complete"@en . . "Fomepizolum"@en . "4-methylpyrazole"@en . . . . . . . . . . . "In healthy volunteers, only 1-3.5% of the administered dose of Antizol\u00AE (7-20 mg/kg oral and IV) was excreted unchanged in the urine, indicating that metabolism is the major route of elimination. In humans, the primary metabolite of Antizol\u00AE is 4-carboxypyrazole (approximately 80-85% of administered dose), which is excreted in the urine. The metabolites of Antizol\u00AE are excreted renally."@en . . . "Humans and other mammals"@en .